BACKGROUND:Cocaine use remains a major problem within methadone maintenance programs. Disulfiram's efficacy in reducing cocaine use has been demonstrated in several trials, but its relative efficacy among individuals who use versus abstain from alcohol remains unclear. Treatment approaches which seek to enhance substance users' involvement in self-help activities (Twelve Step Facilitation, TSF) have been associated with better outcomes among alcohol and cocaine users, but have rarely been evaluated among methadone-maintained cocaine-opioid users. METHODS: We conducted a randomized, placebo-controlled, double blind (for medication condition), factorial (2×2) trial with 4 treatment conditions: Disulfiram plus TSF, disulfiram plus standard counseling only, placebo plus TSF, and placebo plus standard counseling in the context of a community-based methadone maintenance program. Participants (N=112) received either disulfiram (250 mg/d) or placebo in conjunction with daily methadone maintenance. RESULTS: Assignment to TSF was associated with less cocaine use throughout treatment and a higher number of cocaine-negative urines. While there were no significant main effects of disulfiram versus placebo, individuals without an alcohol use disorder demonstrated greater reductions in cocaine use over time when assigned to disulfiram. CONCLUSIONS:TSF appears feasible in this methadone maintenance program and was associated with modest reductions in cocaine use, an often intractable problem in this setting. Support for the efficacy of disulfiram was weaker, as it appeared effective only for those without a current alcohol use disorder for this sample.
RCT Entities:
BACKGROUND:Cocaine use remains a major problem within methadone maintenance programs. Disulfiram's efficacy in reducing cocaine use has been demonstrated in several trials, but its relative efficacy among individuals who use versus abstain from alcohol remains unclear. Treatment approaches which seek to enhance substance users' involvement in self-help activities (Twelve Step Facilitation, TSF) have been associated with better outcomes among alcohol and cocaine users, but have rarely been evaluated among methadone-maintained cocaine-opioid users. METHODS: We conducted a randomized, placebo-controlled, double blind (for medication condition), factorial (2×2) trial with 4 treatment conditions: Disulfiram plus TSF, disulfiram plus standard counseling only, placebo plus TSF, and placebo plus standard counseling in the context of a community-based methadone maintenance program. Participants (N=112) received either disulfiram (250 mg/d) or placebo in conjunction with daily methadone maintenance. RESULTS: Assignment to TSF was associated with less cocaine use throughout treatment and a higher number of cocaine-negative urines. While there were no significant main effects of disulfiram versus placebo, individuals without an alcohol use disorder demonstrated greater reductions in cocaine use over time when assigned to disulfiram. CONCLUSIONS:TSF appears feasible in this methadone maintenance program and was associated with modest reductions in cocaine use, an often intractable problem in this setting. Support for the efficacy of disulfiram was weaker, as it appeared effective only for those without a current alcohol use disorder for this sample.
Authors: Helen M Pettinati; Kyle M Kampman; Kevin G Lynch; Hu Xie; Charles Dackis; Amanda R Rabinowitz; Charles P O'Brien Journal: Addict Behav Date: 2007-11-17 Impact factor: 3.913
Authors: Elizabeth J Santa Ana; Steve Martino; Samuel A Ball; Charla Nich; Tami L Frankforter; Kathleen M Carroll Journal: J Subst Abuse Treat Date: 2008-03-12
Authors: Samuel A Ball; Steve Martino; Charla Nich; Tami L Frankforter; Deborah Van Horn; Paul Crits-Christoph; George E Woody; Jeanne L Obert; Christiane Farentinos; Kathleen M Carroll Journal: J Consult Clin Psychol Date: 2007-08
Authors: Kathleen M Carroll; Steve Martino; Samuel A Ball; Charla Nich; Tami Frankforter; Luis M Anez; Manuel Paris; Lourdes Suarez-Morales; José Szapocznik; William R Miller; Carmen Rosa; Julie Matthews; Chris Farentinos Journal: J Consult Clin Psychol Date: 2009-10
Authors: Mary Hatch-Maillette; Elizabeth A Wells; Suzanne R Doyle; Gregory S Brigham; Dennis Daley; Jessica DiCenzo; Dennis Donovan; Sharon Garrett; Viviana E Horigian; Lindsay Jenkins; Therese Killeen; Mandy Owens; Harold I Perl Journal: J Subst Abuse Treat Date: 2016-06-16
Authors: Madhukar H Trivedi; Tracy L Greer; Chad D Rethorst; Thomas Carmody; Bruce D Grannemann; Robrina Walker; Diane Warden; Kathy Shores-Wilson; Mark Stoutenberg; Neal Oden; Meredith Silverstein; Candace Hodgkins; Lee Love; Cindy Seamans; Angela Stotts; Trey Causey; Regina P Szucs-Reed; Paul Rinaldi; Hugh Myrick; Michele Straus; David Liu; Robert Lindblad; Timothy Church; Steven N Blair; Edward V Nunes Journal: J Clin Psychiatry Date: 2017 Sep/Oct Impact factor: 4.384
Authors: Debra A Cooper; Heather L Kimmel; Daniel F Manvich; Karl T Schmidt; David Weinshenker; Leonard L Howell Journal: J Pharmacol Exp Ther Date: 2014-05-09 Impact factor: 4.030
Authors: Kathleen M Carroll; Brian D Kiluk; Charla Nich; Elise E DeVito; Suzanne Decker; Donna LaPaglia; Dianne Duffey; Theresa A Babuscio; Samuel A Ball Journal: Drug Alcohol Depend Date: 2014-01-31 Impact factor: 4.492
Authors: André Q C Miguel; Ayana Jordan; Brian D Kiluk; Charla Nich; Theresa A Babuscio; Jair J Mari; Kathleen M Carroll Journal: J Subst Abuse Treat Date: 2019-08-28
Authors: André Q C Miguel; Brian D Kiluk; Corey R Roos; Theresa A Babuscio; Charla Nich; Jair J Mari; Kathleen M Carroll Journal: J Subst Abuse Treat Date: 2019-09-05